Jundishapur Journal of Microbiology

Published by: Kowsar

The Prevalence of ISAba1 and ISAba4 in Acinetobacter baumannii Species of Different International Clone Lineages Among Patients With Burning in Tehran, Iran

Abbas Bahador 1 , Reza Raoofian 2 , Zahra Farshadzadeh 1 , Leyli Beitollahi 1 , Azad Khaledi 3 , Sara Rahimi 1 , Masoumeh Mokhtaran 1 , Ali Mehrabi Tavana 4 and Davood Esmaeili 5 , *
Authors Information
1 Department of Microbiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Genetic, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Department of Microbiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
5 Applied Microbiology Research Center, Department of Microbiology, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: July 01, 2015, 8 (7); e17167
  • Published Online: July 27, 2015
  • Article Type: Research Article
  • Received: December 26, 2013
  • Revised: April 20, 2014
  • Accepted: April 27, 2014
  • DOI: 10.5812/jjm.17167v2

To Cite: Bahador A, Raoofian R, Farshadzadeh Z, Beitollahi L, Khaledi A, et al. The Prevalence of ISAba1 and ISAba4 in Acinetobacter baumannii Species of Different International Clone Lineages Among Patients With Burning in Tehran, Iran, Jundishapur J Microbiol. 2015 ; 8(7):e17167. doi: 10.5812/jjm.17167v2.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, Yizhi P. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns. 2014; 40(3): 402-7[DOI][PubMed]
  • 2. Rezaei E, Safari H, Naderinasab M, Aliakbarian H. Common pathogens in burn wound and changes in their drug sensitivity. Burns. 2011; 37(5): 805-7[DOI][PubMed]
  • 3. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010; 65(2): 233-8[DOI][PubMed]
  • 4. Sanchez A, Gattarello S, Rello J. New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli. Semin Respir Crit Care Med. 2011; 32(2): 151-8[DOI][PubMed]
  • 5. Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect. 2007; 13(12): 1192-8[DOI][PubMed]
  • 6. Bogaerts P, Cuzon G, Naas T, Bauraing C, Deplano A, Lissoir B, et al. Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium. Antimicrob Agents Chemother. 2008; 52(11): 4205-6[DOI][PubMed]
  • 7. Lee HY, Chang RC, Su LH, Liu SY, Wu SR, Chuang CH, et al. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan. Int J Antimicrob Agents. 2012; 40(2): 163-7[DOI][PubMed]
  • 8. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006; 258(1): 72-7[DOI][PubMed]
  • 9. He C, Xie Y, Fan H, Kang M, Tao C, Zhang R, et al. Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China. I J Antimicrobial Agents. 2011; [DOI]
  • 10. Nigro SJ, Post V, Hall RM. The multiresistant Acinetobacter baumannii European clone I type strain RUH875 (A297) carries a genomic antibiotic resistance island AbaR21, plasmid pRAY and a cluster containing ISAba1-sul2-CR2-strB-strA. J Antimicrob Chemother. 2011; 66(8): 1928-30[DOI][PubMed]
  • 11. Pajand O, Rezaee MA, Nahaei MR, Mahdian R, Aghazadeh M, Soroush MH, et al. Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: comparison of burn and non-burn strains. Burns. 2013; 39(7): 1414-9[DOI][PubMed]
  • 12. Asadollahi P, Akbari M, Soroush S, Taherikalani M, Asadollahi K, Sayehmiri K, et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns. 2012; 38(8): 1198-203[DOI][PubMed]
  • 13. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol. 2010; 48(12): 4592-4[DOI][PubMed]
  • 14. Wang X, Chen T, Yu R, Lu X, Zong Z. Acinetobacter pittii and Acinetobacter nosocomialis among clinical isolates of the Acinetobacter calcoaceticus-baumannii complex in Sichuan, China. Diagn Microbiol Infect Dis. 2013; 76(3): 392-5[DOI][PubMed]
  • 15. Cockerill FR. Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement;[... provides updated tables for... M02-A11, M07-A9, and M11-A8]. 2013;
  • 16. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3): 268-81[DOI][PubMed]
  • 17. Higgins PG, Lehmann M, Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2010; 35(3): 305[DOI][PubMed]
  • 18. Target amplification for DNA analysis by the polymerase chain reaction. Annales de biologie clinique. : 579-82
  • 19. Bahador A, Taheri M, Pourakbari B, Hashemizadeh Z, Rostami H, Mansoori N, et al. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb Drug Resist. 2013; 19(5): 397-406[DOI][PubMed]
  • 20. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect. 2007; 13(8): 807-15[DOI][PubMed]
  • 21. Safari M, Saidijam M, Bahador A, Jafari R, Alikhani MY. High prevalence of multidrug resistance and metallo-beta-lactamase (MbetaL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. J Res Health Sci. 2013; 13(2): 162-7[PubMed]
  • 22. Chang KC, Lin MF, Lin NT, Wu WJ, Kuo HY, Lin TY, et al. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan. J Microbiol Immunol Infect. 2012; 45(1): 37-42[DOI][PubMed]
  • 23. Mohamed NM, Youssef AA. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt. Microb Drug Resist. 2011; 17(4): 489-95[DOI][PubMed]
  • 24. Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010; 54(12): 4971-7[DOI][PubMed]
  • 25. Kusradze I, Diene SM, Goderdzishvili M, Rolain JM. Molecular detection of OXA carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolates from Iraq and Georgia. Int J Antimicrob Agents. 2011; 38(2): 164-8[DOI][PubMed]
  • 26. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011; 3(2): 68-74[PubMed]
  • 27. Sung JY, Kwon KC, Cho HH, Koo SH. Antimicrobial resistance determinants in imipenem-nonsusceptible Acinetobacter calcoaceticus-baumannii complex isolated in Daejeon, Korea. Korean J Lab Med. 2011; 31(4): 265-70[DOI][PubMed]
  • 28. Kim DH, Choi JY, Kim HW, Kim SH, Chung DR, Peck KR, et al. Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands. Antimicrob Agents Chemother. 2013; 57(11): 5239-46[DOI][PubMed]
  • 29. Martins N, Dalla-Costa L, Uehara AA, Riley LW, Moreira BM. Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion. Infect Genet Evol. 2013; 20: 378-80[DOI][PubMed]
  • 30. Nemec A, Krizova L, Maixnerova M, Diancourt L, van der Reijden TJ, Brisse S, et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother. 2008; 62(3): 484-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments